Wall Street analysts see an 86.45% upside in Biodesix (BDSX): Can the stock really move this high?

robot
Abstract generation in progress

This article analyzes Biodesix (BDSX) stock, highlighting a consensus “Buy” rating from Wall Street analysts and a significant projected upside of 86.45%. It discusses the average price target of $4.67 and outlines each analyst’s specific rating and price target, providing context to the optimistic outlook despite recent stock volatility. The piece also includes key performance data and upcoming earnings information for investors to consider.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments